Antimetastatic role of Smad4 signaling in colorectal cancer.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Gastroenterology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1053/j.gastro.2009.11.004PMID 19909744PMCID PMC2831103
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Smad7 induces hepatic metastasis in colorectal cancer

  2008cited by this paper
• LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• Transforming Growth Factor-β (TGF-β) Signaling Inhibitors in Cancer Therapy

  2008cited by this paper
• Transforming Growth Factor-β in Cancer Therapy

  2008cited by this paper
• Blocking transforming growth factor–beta up‐regulates E‐cadherin and reduces migration and invasion of hepatocellular carcinoma cells

  2008cited by this paper
• Nuclear localization and intensity of staining of nm23 protein is useful marker for breast cancer progression

  2008cited by this paper
• Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis.

  2007cited by this paper
• Loss of Smad4 expression predicts liver metastasis in human colorectal cancer.

  2007cited by this paper
• Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor.

  2006cited by this paper
• Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo

  2006cited by this paper
• Metastasis suppressor genes: From gene identification to protein function and regulation

  2005cited by this paper
• Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

  2005cited by this paper
• Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.

  2005cited by this paper
• SMAD4 as a Prognostic Marker in Colorectal Cancer

  2005cited by this paper
• A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.

  2005cited by this paper
• Cadherins and Catenins: Role in Signal Transduction and Tumor Progression

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.

  2001cited by this paper
• Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-β Antiproliferative Responses in Colon Cancer Cells*

  1999cited by this paper
• Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis

  1999cited by this paper
• High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.

  1993cited by this paper

• The hallmarks of oncogenic signaling: From pathways to resistance in cancer therapy.

  2026cites this paper
• Non-coding RNAs and exosomal ncRNAs in colorectal cancer

  2025cites this paper
• Forward genetic screening in engineered colorectal cancer organoids identifies regulators of metastasis.

  2025cites this paper
• Genomics correlates of brain metastasis and progression in colorectal cancer.

  2025cites this paper
• SMAD4 mutation drives gut microbiome shifts toward tumor progression in colorectal cancer

  2025cites this paper
• The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling

  2024cites this paper
• TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis

  2024cites this paper
• Doxorubicin-induced chemoresistance in Duke’s type B colon adenocarcinoma cell line is aggravated in the presence of TGF-β2 through non-apoptotic cell death

  2024cites this paper
• Single-Cell and Spatial Transcriptome Profiling Identifies the Transcription Factor BHLHE40 as a Driver of EMT in Metastatic Colorectal Cancer.

  2024cites this paper
• Secretion of IL-6 and TGF-β2 by Colon Cancer Cells May Promote Resistance to Chemotherapy

  2024cites this paper
• Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review

  2024cites this paper
• In Vitro Cytotoxicity of Fluorinated Quaternary Ammonium Salts in Colorectal Cancer Cells and In Silico Pharmacology

  2024cites this paper
• TGFβ in pancreas and colorectal cancer: opportunities to overcome therapeutic resistance.

  2024cites this paper
• Polydopamine Nanoparticles Activate Apelin/Apelin Receptor Signaling and Smad3 to Inhibit Tumor Cells in Lung Cancer

  2024cites this paper
• The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer

  2023cites this paper
• Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy

  2023cites this paper
• In Vitro Organoid-Based Assays Reveal SMAD4 Tumor-Suppressive Mechanisms for Serrated Colorectal Cancer Invasion

  2023cites this paper
• APC and P53 mutations synergise to create a therapeutic vulnerability to NOTUM inhibition in advanced colorectal cancer

  2023cites this paper
• SMAD4 and KCNQ3 alterations are associated with lymph node metastases in Oesophageal adenocarcinoma.

  2023cites this paper
• TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.

  2023cites this paper
• TGF-β mediated drug resistance in solid cancer.

  2023cites this paper
• BMI-1 activates hepatic stellate cells to promote the epithelial-mesenchymal transition of colorectal cancer cells

  2023cites this paper
• Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review

  2023cites this paper
• Forward genetic screening in engineered colorectal cancer organoids identifies novel regulators of metastasis

  2023cites this paper
• Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export

  2023cites this paper
• ATOH8 binds SMAD3 to induce cellular senescence and prevent Ras-driven malignant transformation

  2023cites this paper
• Proactive and reactive roles of TGF-β in EMT-induced plasticity.

  2023cites this paper
• The loss of epithelial Smad4 drives immune evasion via CXCL1 while displaying vulnerability to combinatorial immunotherapy in gastric cancer.

  2022cites this paper
• Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules

  2022cites this paper
• Genotype-dependent vulnerability to NOTUM inhibition in colorectal cancer

  2022cites this paper
• Prognostic value of SMAD4 in resectable pancreatic cancer

  2022cites this paper
• CCL7 and TGF-β secreted by MSCs play opposite roles in regulating CRC metastasis in a KLF5/CXCL5 dependent manner.

  2022cites this paper
• Tumour genotypes account for survival differences in right‐ and left‐sided colon cancers

  2022cites this paper
• Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience

  2022cites this paper
• Colorectal Cancer and Adjacent Normal Mucosa Differ in Apoptotic and Inflammatory Protein Expression

  2022cites this paper
• Arid5a Promotes Immune Evasion by Augmenting Tryptophan Metabolism and Chemokine Expression

  2021cites this paper
• Assessment of clinical variables as predictive markers in the development and progression of colorectal cancer

  2021cites this paper
• A novel role of PRL in regulating epithelial cell density by inducing apoptosis at confluence.

  2021cites this paper
• The Role of Kinase Inhibitors in Cancer Therapies

  2021cites this paper
• Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer

  2021cites this paper
• Potential therapy with the inhibitor of TGF-β receptors LY2109761 for oral squamous cell carcinoma

  2021cites this paper
• SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response.

  2021cites this paper
• The Multifaceted Role of TGF-β in Gastrointestinal Tumors

  2021cites this paper
• Smad4 With R361 Hotspot Mutations Retains The Ability To Bind To Lef1 And Boosts Wnt Signaling In Colorectal Cancer Cells

  2021cites this paper
• Targeting transforming growth factor-β signaling for enhanced cancer chemotherapy

  2021cites this paper
• SMAD4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes

  2021cites this paper
• TGF-beta signaling in liver metastasis

  2020cites this paper
• Deep Next Generation Sequencing Identifies Somatic Mutational Signature in Egyptian Colorectal Cancer Patients

  2020cites this paper
• MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer

  2020cites this paper
• SMAD 4 haploinsu � ciency in small intestinal neuroendocrine tumors

  2020cites this paper
• Emerging Role and Therapeutic Potential of lncRNAs in Colorectal Cancer

  2020cites this paper
• A Novel Approach for Monitoring TGF-ß Signaling in vivo in Colon Cancer.

  2020cites this paper
• TGF‐β signaling in liver metastasis

  2020cites this paper
• Click‐Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga‐68‐Peptide: Enhanced Contrast for in‐Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts

  2020cites this paper
• Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer.

  2020cites this paper
• FCHO1560-571 peptide, a PKB kinase motif, inhibits tumor progression.

  2020cites this paper
• Tracking a TGF-β activator in vivo: sensitive PET imaging of αvβ8-integrin with the Ga-68-labeled cyclic RGD octapeptide trimer Ga-68-Triveoctin

  2020cites this paper
• Role of Matrix Metalloproteinases in Colorectal Cancer

  2020cites this paper
• Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells

  2020cites this paper
• SMAD4 haploinsufficiency in small intestinal neuroendocrine tumors

  2020cites this paper
• PTPRε Acts as a Metastatic Promoter in Hepatocellular Carcinoma by Facilitating Recruitment of SMAD3 to TGF‐β Receptor 1

  2020cites this paper
• Metastatic components in colorectal cancer

  2019cites this paper
• Harmonized Autophagy Versus Full-Fledged Hepatitis B Virus: Victorious or Defeated

  2019cites this paper
• The impact of somatic SMAD4 mutations in colorectal liver metastases.

  2019cites this paper
• Parthenolide inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in colorectal cancer cells

  2019cites this paper
• Linking stemness with colorectal cancer initiation, progression, and therapy

  2019cites this paper
• Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review

  2019cites this paper
• miRNA-448 inhibits cell growth by targeting BCL-2 in hepatocellular carcinoma.

  2019cites this paper
• The mechanism of the premetastatic niche facilitating colorectal cancer liver metastasis generated from myeloid-derived suppressor cells induced by the S1PR1–STAT3 signaling pathway

  2019cites this paper
• Transforming growth factor β signaling pathway: A promising therapeutic target for cancer

  2019cites this paper
• Pathways of colorectal carcinogenesis

  2019cites this paper
• Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis

  2019cites this paper
• Smad4 gene silencing enhances the chemosensitivity of human lymphoma cells to adriamycin via inhibition of the activation of transforming growth factor β signaling pathway

  2019cites this paper
• Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment

  2019cites this paper
• Small intestinal neuroendocrine tumours - Disease models, tumour development, and remedy

  2019cites this paper
• HLTF suppresses the migration and invasion of colorectal cancer cells via TGF‑β/SMAD signaling in vitro.

  2018cites this paper
• Autophagy: The multi‐purpose bridge in viral infections and host cells

  2018cites this paper
• Pancreatic Cancer: Precancerous Lesions

  2018cites this paper
• Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma

  2018cites this paper
• Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer

  2018cites this paper
• miRNA expression profiles in Smad4-positive and Smad4-negative SW620 human colon cancer cells detected by next-generation small RNA sequencing

  2018cites this paper
• Phytoestrogens as a Natural Source for the Possible Colon Cancer Treatment

  2018cites this paper
• Transforming Growth Factor Beta 2 Inhibits Growth and Proliferation Potential of Smad4 and p53 Mutated Human Colon Adenocarcinoma Cells

  2018cites this paper
• TGF-ß and Tyrosine Kinases: Context in Colorectal Cancer

  2018cites this paper
• BMP signaling in homeostasis, transformation and inflammatory response of intestinal epithelium

  2018cites this paper
• Inhibition of microRNA‐21‐3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA‐binding protein with multiple splicing through Smad4/extra cellular signal‐regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells

  2018cites this paper
• Role of epithelial-mesenchymal transition in the development of lung cancer

  2018cites this paper
• Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature

  2018cites this paper
• The Role of TGF-andbeta; in Gastrointestinal Cancers

  2018cites this paper
• Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells

  2018cites this paper
• Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.

  2018cites this paper
• Co‐delivery nanoparticle to overcome metastasis promoted by insufficient chemotherapy

  2018cites this paper
• Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer

  2017cites this paper
• When Neighbors Talk: Colon Cancer Cell Invasion and Tumor Microenvironment Myofibroblasts.

  2017cites this paper
• SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells

  2017influential citation
• Long non-coding RNA TUG 1 can promote proliferation and migration of pancreatic cancer via EMT pathway

  2017cites this paper
• MiR-146 b protects cardiomyocytes injury in myocardial ischemia / reperfusion by targeting Smad 4

  2017cites this paper
• Transforming growth factor-β: A therapeutic target for cancer

  2017cites this paper
• Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer

  2017cites this paper
• Molecular characterization of pro-metastatic functions of β4-integrin in colorectal cancer

  2017cites this paper